US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 8.5450
  • +0.3660+4.47%
Trading May 13 15:13 ET
25.29MMarket Cap-693P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.37%-32.16M
28.69%-6.42M
53.93%-5.51M
-29.92%-9.26M
-27.46%-10.97M
-38.04%-36.7M
-36.06%-9M
-87.55%-11.97M
6.28%-7.13M
-43.79%-8.61M
Net income from continuing operations
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
-66.51%-9.9M
Other non cash items
-2.79%174K
-28.57%25K
114.29%75K
-43.08%37K
-15.91%37K
5.92%179K
-20.45%35K
-18.60%35K
54.76%65K
10.00%44K
Change In working capital
1,946.38%1.27M
36.64%869K
202.28%2.92M
-153.92%-1.55M
-33.01%-963K
94.69%-69K
312.00%636K
-265.79%-2.85M
259.04%2.87M
20.87%-724K
-Change in prepaid assets
225.25%2.62M
-33.97%383K
178.11%2.31M
-219.30%-989K
267.27%925K
-193.83%-2.1M
1,015.38%580K
-264.22%-2.95M
142.45%829K
9.20%-553K
-Change in payables and accrued expense
-216.55%-2.57M
-88.52%24K
37.55%315K
-139.70%-752K
-1,598.43%-2.16M
81.48%2.21M
239.33%209K
-88.79%229K
263.28%1.89M
-126.35%-127K
-Change in other current liabilities
36.31%-114K
54.29%-16K
31.43%-24K
43.08%-37K
15.91%-37K
-5.92%-179K
20.45%-35K
18.60%-35K
-54.76%-65K
-10.00%-44K
-Change in other working capital
--1.33M
--478K
443.01%319K
--231K
--306K
----
----
95.52%-93K
----
----
Cash from discontinued investing activities
Operating cash flow
12.37%-32.16M
28.69%-6.42M
53.93%-5.51M
-29.92%-9.26M
-27.46%-10.97M
-38.04%-36.7M
-36.06%-9M
-87.55%-11.97M
6.28%-7.13M
-43.79%-8.61M
Investing cash flow
Cash flow from continuing investing activities
102.46%651K
93.18%-1.81M
4.66M
13.85M
-16.05M
-26.5M
-26.5M
0
0
0
Net investment purchase and sale
102.46%651K
93.18%-1.81M
--4.66M
--13.85M
---16.05M
---26.5M
---26.5M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
102.46%651K
93.18%-1.81M
--4.66M
--13.85M
---16.05M
---26.5M
---26.5M
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-88.85%1.07M
-100.05%-1K
-101.33%-49K
-100.03%-1K
1.12M
1,452.51%9.58M
201,300.00%2.01M
3,708.25%3.69M
6,351.67%3.87M
0
Net common stock issuance
-88.85%1.07M
-100.05%-1K
-101.33%-49K
-100.03%-1K
--1.12M
--9.58M
--2.01M
--3.69M
--3.87M
--0
Cash from discontinued financing activities
Financing cash flow
-88.85%1.07M
-100.05%-1K
-101.33%-49K
-100.03%-1K
--1.12M
1,452.51%9.58M
201,300.00%2.01M
3,708.25%3.69M
6,351.67%3.87M
--0
Net cash flow
Beginning cash position
-59.08%37.14M
-78.87%14.93M
-79.93%15.83M
-86.31%11.24M
-59.08%37.14M
-22.25%90.77M
-27.47%70.63M
-23.89%78.9M
-26.12%82.16M
-22.25%90.77M
Current changes in cash
43.22%-30.45M
75.43%-8.23M
89.04%-907K
240.78%4.59M
-200.93%-25.9M
-106.46%-53.62M
-406.21%-33.49M
-31.66%-8.27M
56.82%-3.26M
-55.74%-8.61M
End cash Position
-81.97%6.7M
-81.97%6.7M
-78.87%14.93M
-79.93%15.83M
-86.31%11.24M
-59.08%37.14M
-59.08%37.14M
-27.47%70.63M
-23.89%78.9M
-26.12%82.16M
Free cash flow
12.37%-32.16M
28.69%-6.42M
53.93%-5.51M
-29.92%-9.26M
-27.46%-10.97M
-38.04%-36.7M
-36.06%-9M
-87.55%-11.97M
6.28%-7.13M
-43.79%-8.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.37%-32.16M28.69%-6.42M53.93%-5.51M-29.92%-9.26M-27.46%-10.97M-38.04%-36.7M-36.06%-9M-87.55%-11.97M6.28%-7.13M-43.79%-8.61M
Net income from continuing operations 10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M-66.51%-9.9M
Other non cash items -2.79%174K-28.57%25K114.29%75K-43.08%37K-15.91%37K5.92%179K-20.45%35K-18.60%35K54.76%65K10.00%44K
Change In working capital 1,946.38%1.27M36.64%869K202.28%2.92M-153.92%-1.55M-33.01%-963K94.69%-69K312.00%636K-265.79%-2.85M259.04%2.87M20.87%-724K
-Change in prepaid assets 225.25%2.62M-33.97%383K178.11%2.31M-219.30%-989K267.27%925K-193.83%-2.1M1,015.38%580K-264.22%-2.95M142.45%829K9.20%-553K
-Change in payables and accrued expense -216.55%-2.57M-88.52%24K37.55%315K-139.70%-752K-1,598.43%-2.16M81.48%2.21M239.33%209K-88.79%229K263.28%1.89M-126.35%-127K
-Change in other current liabilities 36.31%-114K54.29%-16K31.43%-24K43.08%-37K15.91%-37K-5.92%-179K20.45%-35K18.60%-35K-54.76%-65K-10.00%-44K
-Change in other working capital --1.33M--478K443.01%319K--231K--306K--------95.52%-93K--------
Cash from discontinued investing activities
Operating cash flow 12.37%-32.16M28.69%-6.42M53.93%-5.51M-29.92%-9.26M-27.46%-10.97M-38.04%-36.7M-36.06%-9M-87.55%-11.97M6.28%-7.13M-43.79%-8.61M
Investing cash flow
Cash flow from continuing investing activities 102.46%651K93.18%-1.81M4.66M13.85M-16.05M-26.5M-26.5M000
Net investment purchase and sale 102.46%651K93.18%-1.81M--4.66M--13.85M---16.05M---26.5M---26.5M--0--0--0
Cash from discontinued investing activities
Investing cash flow 102.46%651K93.18%-1.81M--4.66M--13.85M---16.05M---26.5M---26.5M--0--0--0
Financing cash flow
Cash flow from continuing financing activities -88.85%1.07M-100.05%-1K-101.33%-49K-100.03%-1K1.12M1,452.51%9.58M201,300.00%2.01M3,708.25%3.69M6,351.67%3.87M0
Net common stock issuance -88.85%1.07M-100.05%-1K-101.33%-49K-100.03%-1K--1.12M--9.58M--2.01M--3.69M--3.87M--0
Cash from discontinued financing activities
Financing cash flow -88.85%1.07M-100.05%-1K-101.33%-49K-100.03%-1K--1.12M1,452.51%9.58M201,300.00%2.01M3,708.25%3.69M6,351.67%3.87M--0
Net cash flow
Beginning cash position -59.08%37.14M-78.87%14.93M-79.93%15.83M-86.31%11.24M-59.08%37.14M-22.25%90.77M-27.47%70.63M-23.89%78.9M-26.12%82.16M-22.25%90.77M
Current changes in cash 43.22%-30.45M75.43%-8.23M89.04%-907K240.78%4.59M-200.93%-25.9M-106.46%-53.62M-406.21%-33.49M-31.66%-8.27M56.82%-3.26M-55.74%-8.61M
End cash Position -81.97%6.7M-81.97%6.7M-78.87%14.93M-79.93%15.83M-86.31%11.24M-59.08%37.14M-59.08%37.14M-27.47%70.63M-23.89%78.9M-26.12%82.16M
Free cash flow 12.37%-32.16M28.69%-6.42M53.93%-5.51M-29.92%-9.26M-27.46%-10.97M-38.04%-36.7M-36.06%-9M-87.55%-11.97M6.28%-7.13M-43.79%-8.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg